Study for people transitioning gender-affirming care
Part of Mental health clinical trials.
This study looks at people who are preparing to start gender-affirming hormone treatment. It may help researchers understand what support is needed before hormones begin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of gender incongruence or gender dysphoria
- You can read and sign consent after being fully informed
- You have not started gender-affirming hormone treatment yet
- You are not pregnant
- You are not breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at starting gender-affirming hormone therapy (GAHT) for transgender people who have never had these treatments before. It may help you learn whether this approach is safe and effective for your goals as you begin care.
This trial is designed to improve how healthcare is provided to young people who are exploring their gender identity. If you have already been accepted into a gender identity service, you may be able to join and help shape better care for others.
This study looks at how gender-affirming hormone therapy affects the heart and blood vessels in transgender people. If you've been on hormones for at least a year, researchers want to check your cardiovascular health to better understand long-term risks and benefits.
This study follows transgender and gender diverse people of all ages 16 and older to learn more about their health and well-being over time. It is for those who have a diagnosis of gender incongruence and are either starting, continuing, or have stopped gender affirming therapy.
This trial follows all patients referred to the Center for Gender Identity in Copenhagen to learn more about their experiences and needs. If you are referred there and can read Danish, you may join.
This study looks back at the medical records of transgender young people who began gender-affirming care at Strasbourg University Hospital before age 18. It helps doctors understand their experiences and improve future care.
Hear when a new Gender Incongruence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.